Tag: nonsmall

Latest News

New immunotherapy for metastatic non-small cell lung cancer shows promise in clinical trial

Newsemia
A new type of immunotherapy treatment for metastatic non-small cell lung cancer (NSCLC) is being tested by Missak Haigentz, Jr., MD, medical director of hematology...
Latest News

AI could enhance prediction of treatment response among patients with non-small cell lung cancer

Newsemia
Artificial intelligence deep learning algorithms may predict response to systemic treatment for non-small cell lung cancer. Source link...
AI/ML

Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients.

Newsemia
Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients. J Pharm Biomed Anal. 2020 Feb 29;185:113220 Authors: Noreldeen HAA, Du L, Li...
Pharma / Biotech

Evaluation of gefitinib systemic exposure in EGFR-mutated non-small cell lung cancer patients with gefitinib-induced severe hepatotoxicity.

Newsemia
Related Articles Evaluation of gefitinib systemic exposure in EGFR-mutated non-small cell lung cancer patients with gefitinib-induced severe hepatotoxicity. Cancer Chemother Pharmacol. 2020 Feb 10;: Authors:...
Pharma / Biotech

Tumor Time-Course Predicts Overall Survival in Non-Small Cell Lung Cancer Patients Treated with Atezolizumab: Dependency on Follow-Up Time.

Newsemia
Related Articles Tumor Time-Course Predicts Overall Survival in Non-Small Cell Lung Cancer Patients Treated with Atezolizumab: Dependency on Follow-Up Time. CPT Pharmacometrics Syst Pharmacol. 2020...
Pharma / Biotech

Discovery of a Furanopyrimidine-Based Epidermal Growth Factor Receptor Inhibitor (DBPR112) as a Clinical Candidate for the Treatment of Non-Small Cell Lung Cancer.

Newsemia
Discovery of a Furanopyrimidine-Based Epidermal Growth Factor Receptor Inhibitor (DBPR112) as a Clinical Candidate for the Treatment of Non-Small Cell Lung Cancer. J Med Chem....
Latest News

TAGRISSO Is the Only 1st-line Treatment for EGFR-Mutated Non-Small Cell Lung Cancer to Deliver a Median Overall Survival of More Than Three Years

Newsemia
WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca today presented detailed overall survival (OS) results from the Phase III FLAURA trial of TAGRISSO® (osimertinib) in the 1st-line treatment of adult...
Latest News

Prognostic and predictive value of histogram analysis in patients with non-small cell lung cancer refractory to platinum treated by nivolumab: A multicentre retrospective study

Newsemia
Ravanelli, M; Agazzi, GM; Milanese, G; Roca, E; Silva, M; Tiseo, M; Rondi, P; … Farina, D; + view all Ravanelli, M; Agazzi, GM; Milanese,...
Latest News

Structure and Dynamics of the EGF Receptor as Revealed by Experiments and Simulations and Its Relevance to Non-Small Cell Lung Cancer

Newsemia
Martin-Fernandez, ML; Clarke, DT; Roberts, SK; Zanetti-Domingues, LC; Gervasio, FL; (2019) Structure and Dynamics of the EGF Receptor as Revealed by Experiments and Simulations and...
Latest News

Entrectinib (Roche/Chugai/Nerviano): Global Drug Overview & Outlook with Sales for Non-small Cell Lung Cancer (NSCLC) by Country 2017-2026 – ResearchAndMarkets.com

Newsemia
DUBLIN–(BUSINESS WIRE)–The "Entrectinib" report has been added to ResearchAndMarkets.com's offering. Entrectinib (Roche/Chugai/Nerviano) is a selective tyrosine kinase inhibitor (TKI) of the tropomyosin receptor kinases (Trk)...
Pharma / Biotech

Development and validation of a sensitive LC-MS/MS method for determination of gefitinib and its major metabolites in human plasma and its application in non-small cell lung cancer patients.

Newsemia
Related Articles Development and validation of a sensitive LC-MS/MS method for determination of gefitinib and its major metabolites in human plasma and its application in...
Pharma / Biotech

ASCEND-8 pharmacokinetic, safety, and efficacy data for ceritinib 450 mg with food in patients with anaplastic lymphoma kinase-positive non-small cell lung Cancer: A clinical perspective.

Newsemia
Related Articles ASCEND-8 pharmacokinetic, safety, and efficacy data for ceritinib 450 mg with food in patients with anaplastic lymphoma kinase-positive non-small cell lung Cancer: A clinical...
Cardiology

Risk factors of postoperative acute lung injury following lobectomy for nonsmall cell lung cancer.

Newsemia
Related Articles Risk factors of postoperative acute lung injury following lobectomy for nonsmall cell lung cancer. Medicine (Baltimore). 2019 Mar;98(13):e15078 Authors: Kim HJ, Cha SI,...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World